Author:
Ni Jinsong,Ouyang Hui,Aiello Mauro,Seto Carmai,Borbridge Lisa,Sakuma Takeo,Ellis Robert,Welty Devin,Acheampong Andrew
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference22 articles.
1. Food and Drug Administration. Guidance for industry, investigators, and reviewers—exploratory IND studies. January (2006).
2. European Medicines Agency (EMEA), Committee for Medicinal Products for Human Use (CHMP). 2004. Position paper on non-clinical safety studies to support clinical trials with a single microdose. CPMP, SWP, 2599, 02, Rev 1, London. 23 June (2004).
3. R. C. Garner, and G. Lappin. Commentary, the phase 0 microdosing concept. Br. J. Clin. Pharmacol. 61(4):367–370 (2006).
4. G. R. Zanni, and J. Y. Wick. Microdosing: the new pharmacokinetic paradigm? Consult Pharm. 21(10):756–776 (2006).
5. R. C. Garner. Less is more: the human microdosing concept. Drug Discov. Today 10(7):449–451 (2005).
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献